Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Chem Res Toxicol ; 31(10): 1052-1060, 2018 10 15.
Artículo en Inglés | MEDLINE | ID: mdl-30203651

RESUMEN

1,3,8-Trihydroxy-6-methylanthraquinone (emodin), a widely existing natural product in herbal medicines, has been reported to be hepatotoxic, but the exact underlying mechanism is still not fully understood. The objective of the present study was to evaluate the role of CYP3A and glutathione (GSH) in emodin-induced liver injury. Primary human hepatocytes were exposed to emodin with and without addition of CYP3A inducer/inhibitor and GSH synthesis inhibitor. It was found that emodin-mediated cytotoxicity increased when CYP3A was activated and GSH was depleted. Hepatotoxicity induced by emodin in rats by activation/inhibition of CYP3A and depletion of GSH was further investigated. Administration of emodin in combination with l-buthionine sulfoximine (BSO) or dexamethasone (DEX) resulted in aggravated liver injury, whereas pretreatment with ketoconazole (KTZ) suppressed the side effects caused by emodin. In addition, plasma exposure of emodin and its glucuronide metabolite were measured by ultraperformance liquid chromatography triple quadrupole mass spectrometry. Emodin and its glucuronide were lower in BSO-, DEX-, and KTZ- co-treated rats compared with those administered with emodin alone. In conclusion, these mentioned results suggested that CYP3A induction and GSH depletion might be involved in hepatotoxicity induced by emodin. This study may help to understand the risk factors and the mechanism of hepatotoxicity of emodin in humans.


Asunto(s)
Citocromo P-450 CYP3A/metabolismo , Emodina/toxicidad , Glutatión/metabolismo , Animales , Butionina Sulfoximina/toxicidad , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Enfermedad Hepática Inducida por Sustancias y Drogas/etiología , Enfermedad Hepática Inducida por Sustancias y Drogas/metabolismo , Cromatografía Líquida de Alta Presión , Citocromo P-450 CYP3A/química , Inhibidores del Citocromo P-450 CYP3A/toxicidad , Dexametasona/toxicidad , Emodina/análisis , Emodina/metabolismo , Hepatocitos/citología , Hepatocitos/efectos de los fármacos , Hepatocitos/metabolismo , Humanos , Masculino , Espectrometría de Masas , Ratas , Ratas Sprague-Dawley
2.
J Proteomics ; 177: 40-47, 2018 04 15.
Artículo en Inglés | MEDLINE | ID: mdl-29438852

RESUMEN

Polygoni Multiflori Radix (PMR) has been commonly used as a tonic in China for centuries. However, PMR-associated hepatotoxicity is becoming a safety issue. Cholestasis often occurs in PMR-induced hepatotoxicity in clinical medicine, but the exact mechanism is not completely understood. An RNA-Seq method was employed, in the present study, to explore the molecular mechanism of cholestatic liver injury induced by PMR, characterized by the hepatic transcriptional response in rats exposed to 1 and 20 g/kg PMR for 90 days. Pathological changes seen in rat livers exposed to PMR included increased bile ducts in portal areas and biliary epithelial cell hyperplasia, which were accompanied by the elevation of serum biochemistries. Dose-dependent increases in the expression of 14 transcripts encoding enzymes involved in the cholesterol biosynthetic pathway were identified. Furthermore, cholesterol 7-alpha hydroxylase (Cyp7a1), a rate-limiting enzyme in the synthesis of bile acids (BAs) from cholesterol, was found to be upregulated by PMR treatment. Protein analysis by western blot suggested that expression of 3-hydroxy-3-methylglutaryl CoA reductase (Hmgcr) and Cyp7a1 were increased in a dose-dependent manner. Collectively, the present study demonstrates that PMR upregulates key enzymes for biosynthesis of cholesterol and BA, which poses the risk of cholestatic liver injury. SIGNIFICANCE: To the best of our knowledge, this is the first transcriptome analysis to highlight the main molecular changes occurring in rats chronic exposed to PMR. We have identified 39 specific differentially expressed genes (DEGs) that were present in various comparisons. A total of 14 of these altered gene transcripts were associated with cholesterol biosynthesis. Another factor of great importance in our opinion seemed to be the enhancement of bile acid (BA) biosynthesis, which were closely linked to cholesterol biosynthesis or metabolism. Our findings suggested that the disturbance on balance of BA formation and elimination might lead to a BA overload in hepatocytes, thereby resulting in liver injury.


Asunto(s)
Enfermedad Hepática Inducida por Sustancias y Drogas/diagnóstico , Colestasis/inducido químicamente , Perfilación de la Expresión Génica/métodos , Polygonum/toxicidad , Animales , Ácidos y Sales Biliares/biosíntesis , Vías Biosintéticas/genética , Colesterol/biosíntesis , Hígado/enzimología , Hígado/metabolismo , Hígado/patología , Ratas , Regulación hacia Arriba
3.
Chem Res Toxicol ; 30(10): 1865-1873, 2017 10 16.
Artículo en Inglés | MEDLINE | ID: mdl-28899093

RESUMEN

The use of herbal medicines continues to expand globally, meanwhile, herb-associated hepatotoxicity is becoming a safety issue. As a conventional Chinese medicinal herb, Dioscorea bulbifera rhizome (DBR) has been documented to cause hepatic toxicity. However, the exact underlying mechanism remains largely unexplored. In the present study, we aimed to profile entire endogenous metabolites in a biological system using a multisample integrated metabolomics strategy. Our findings offered additional insights into the molecular mechanism of the DBR-induced hepatotoxicity. We identified different metabolites from rat plasma, urine, and feces by employing gas chromatography-mass spectrometry in combination with multivariate analysis. In total, 55 metabolites distributed in 33 metabolic pathways were identified as being significantly altered in DBR-treated rats. Correlation network analysis revealed that the hub metabolites of hepatotoxicity were mainly associated with amino acid, bile acid, purine, pyrimidine, lipid, and energy metabolism. As such, DBR affected the physiological and biological functions of liver via the regulation of multiple metabolic pathways to an abnormal state. Notably, our findings also demonstrated that the multisample integrated metabolomics strategy has a great potential to identify more biomarkers and pathways in order to elucidate the mechanistic complexity of toxicity of traditional Chinese medicine.


Asunto(s)
Enfermedad Hepática Inducida por Sustancias y Drogas/metabolismo , Dioscorea/química , Medicamentos Herbarios Chinos/toxicidad , Hígado/efectos de los fármacos , Metabolómica , Rizoma/química , Animales , Enfermedad Hepática Inducida por Sustancias y Drogas/patología , Medicamentos Herbarios Chinos/administración & dosificación , Hígado/metabolismo , Hígado/patología , Masculino , Ratas , Ratas Sprague-Dawley
4.
Front Pharmacol ; 8: 446, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28729838

RESUMEN

Polygoni Multiflori Radix (PMR) has been commonly used as a tonic in China for centuries. PMR-associated hepatotoxicity has been drawing increasingly more attention in recent years in parallel with its wide utilization. Anthraquinones (AQs) are recognized as the main hepatotoxic components in PMR. However, the exact underlying mechanism of AQs poisoning is still not fully understood. Herein, we proposed a hypothesis that metabolic activation of AQs such as emodin was involved in PMR-induced liver injury, AQs followed to generate the electrophilic reactive metabolites and subsequently formed covalent adduct with cellular nucleophiles in the liver to exert hepatotoxicity. In the present study, the link of cytotoxicity of PMR in primary human hepatocytes and the depletion of glutathione (GSH) was investigated by MTT assay and UHPLC-QqQ-MS/MS analysis. The results showed that PMR depleted GSH and therefore induced cytotoxicity. Then, emodin-GSH adduct was identified in bile of liver injured rats after intragastric administration of PMR or emodin with the aid of UHPLC-QTOF-MS/MS method. Our findings not only provided confirmative evidence that the mechanism of hepatotoxicity induced by AQs in PMR involved key metabolic steps, but also revealed that emodin-GSH adduct had potential to be further developed as a sensitive and traceable biomarker for the assessment of PMR-induced liver injury.

5.
Chin J Nat Med ; 15(6): 451-457, 2017 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-28629535

RESUMEN

Polygoni Multiflori Radix (PMR) has been commonly used as a tonic in China for centuries. However, PMR-associated hepatotoxicity is becoming a safety issue. In our previous in vivo study, an interaction between stilbenes and anthraquinones has been discovered and a hypothesis is proposed that the interaction between stilbene glucoside-enriching fraction and emodin may contribute to the side effects of PMR. To further support our previous in vivo results in rats, the present in vitro study was designed to evaluate the effects of 2, 3, 5, 4'-tetrahydroxystilbene-2-O-ß-D-glucopyranoside (TSG) on the cellular absorption and human liver microsome metabolism of emodin. The obtained results indicated that the absorption of emodin in Caco-2 cells was enhanced and the metabolism of emodin in human liver microsomes was inhibited after TSG treatment. The effects of the transport inhibitors on the cellular emodin accumulation were also examined. Western blot assay suggested that the depressed metabolism of emodin could be attributed to the down-regulation of UDP-glucuronosyltransferases (UGTs) 1A8, 1A10, and 2B7. These findings definitively demonstrated the existence of interaction between TSG and emodin, which provide a basis for a better understanding of the underlying mechanism for PMR-induced liver injury.


Asunto(s)
Emodina/metabolismo , Fallopia multiflora/efectos adversos , Glucósidos/toxicidad , Estilbenos/toxicidad , Células CACO-2 , Enfermedad Hepática Inducida por Sustancias y Drogas/etiología , Emodina/análisis , Glucuronosiltransferasa/antagonistas & inhibidores , Humanos , Raíces de Plantas
6.
Food Chem Toxicol ; 108(Pt B): 532-542, 2017 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-28237774

RESUMEN

Polygoni Multiflori Radix (PMR) has been widely used as a tonic for centuries. However, hepatotoxicity cases linked to PMR have been frequently reported and appropriate biomarkers for clinical diagnosis are currently lacking. Here, an approach using UPLC-QqQ/MS-based targeted metabolomics of bile acids (BAs) complemented with biochemistry and histopathology was applied to characterize the development and recovery processes of PMR-induced hepatotoxicity in rats and to identify biomarkers. The expression of bile salt export pump (Bsep) and sodium taurocholate cotransporting polypeptide (Ntcp) were evaluated to investigate the underlying mechanism. Steatosis and inflammatory cell infiltration were observed in PMR-treated rats, which were accompanied by the elevation of serum biochemistry. The metabolic profiles of BAs were analyzed by Principal Component Analysis, hyodeoxycholic acid (HDCA) in serum and tauro-ß-muricholic acid (TßMCA) in urine were identified as potential biomarkers for PMR-induced hepatotoxicity. The elevated expression of Bsep and decreased expression of Ntcp in the liver of PMRtreated rats indicated that hepatotoxicity was related to the disorders of BAs metabolism. Our study demonstrated that BAs may be used for clinical diagnosis of PMR-induced hepatotoxicity. Urine TßMCA was identified as a promising biomarker to facilitate the clinical monitoring of PMR-induced hepatotoxicity and may serve as potential therapeutic target.


Asunto(s)
Enfermedad Hepática Inducida por Sustancias y Drogas/metabolismo , Fallopia multiflora/química , Ácido Taurocólico/análogos & derivados , Animales , Ácidos y Sales Biliares/sangre , Biomarcadores , Relación Dosis-Respuesta a Droga , Medicamentos Herbarios Chinos , Masculino , Metabolómica , Ratas , Ratas Sprague-Dawley , Ácido Taurocólico/metabolismo
7.
J Chromatogr A ; 1450: 53-63, 2016 Jun 10.
Artículo en Inglés | MEDLINE | ID: mdl-27157425

RESUMEN

Gastrodia elata tuber (GET) has been widely used as a famous herbal medicine in China and other East Asian countries. In this work, we developed a comprehensive strategy integrating targeted and non-targeted analyses for quality evaluation and discrimination of GET from different geographical origins and cultivars. Firstly, 43 batches of GET samples of five cultivars from three regions in China were efficiently quantified by a "single standard to determine multi-components" (SSDMC) method. Six marker compounds were simultaneously determined within 11min using gastrodin as the internal standard. It showed that samples from different regions and cultivars could not be differentiated by the contents of six marker compounds. Secondly, a non-targeted metabolite profiling analysis was performed by ultrahigh-performance liquid chromatography quadrupole time-of-flight mass spectrometry (UHPLC-QTOF/MS). Samples from different geographical origins and cultivars were clearly discriminated by principal component analysis (PCA) and partial least-squares discriminant analysis (PLS-DA). 147 discriminant ions contributing to the group separation were selected from 1194 aligned variables. Furthermore, based on the relative intensities of discriminant ions, support vector machines (SVM) was employed to predict the geographical origins of GET. The obtained SVM model showed excellent prediction performance with an average prediction accuracy of 100%. These results demonstrated that the UHPLC-QTOF/MS-based non-targeted metabolite profiling analysis, as a vital supplement to targeted analysis, can be used to discriminate the geographical origins and cultivars of GET.


Asunto(s)
Medicamentos Herbarios Chinos/análisis , Medicamentos Herbarios Chinos/metabolismo , Gastrodia/química , Gastrodia/clasificación , Metabolómica/métodos , Raíces de Plantas/química , Raíces de Plantas/metabolismo , Alcoholes Bencílicos/análisis , China , Cromatografía Líquida de Alta Presión , Análisis Discriminante , Medicamentos Herbarios Chinos/química , Medicamentos Herbarios Chinos/clasificación , Gastrodia/metabolismo , Mapeo Geográfico , Glucósidos/análisis , Análisis de los Mínimos Cuadrados , Espectrometría de Masas , Metaboloma , Raíces de Plantas/clasificación , Plantas Medicinales/química , Plantas Medicinales/clasificación , Plantas Medicinales/metabolismo , Análisis de Componente Principal , Máquina de Vectores de Soporte
8.
J Ethnopharmacol ; 175: 67-74, 2015 Dec 04.
Artículo en Inglés | MEDLINE | ID: mdl-26376237

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: Herb pair serves as the basic building block of a traditional Chinese medicine (TCM) formula. The rhubarb-gardenia herb pair (RGHP), composed of rhubarb and gardenia, has meaningful clinical effects to cure cholestasis diseases. This study was designed to confirm the expected synergistic effects of RGHP at pharmacodynamic and pharmacokinetic levels. MATERIALS AND METHODS: Thirty male Sprague-Dawley rats were divided into control, model and drug-treated groups. After intragastrically administrated with α-naphthylisothiocyanate (ANIT) to induce cholestasis, rats were treated with rhubarb, gardenia or RGHP. For pharmacodynamic study, biochemical and histopathological tests were performed to assess the hepatoprotective effects. While for pharmacokinetic study, a LC-MS method was developed for determination of five main chemical markers, namely genipin, rhein, aloe emodin, emodin and chrysophanol in rat plasma. RESULTS: The biochemical and histopathological tests suggested that RGHP exerted enhanced hepatoprotective effects against the ANIT-induced cholestasis compared with single herbs. The pharmacokinetic study indicated RGHP could significantly elevate systemic exposure level and prolong retention time of five markers in comparison with rhubarb or gardenia alone. CONCLUSIONS: The present study demonstrated the synergistic effects of RGHP in ANIT-induced cholestatic rats at pharmacodynamic and pharmacokinetic levels, and has significant enlightenments for the rational use of the related TCM formulas containing RGHP.


Asunto(s)
Colestasis , Gardenia , Extractos Vegetales , Sustancias Protectoras , Rheum , 1-Naftilisotiocianato , Alanina Transaminasa/sangre , Fosfatasa Alcalina/sangre , Animales , Antraquinonas/sangre , Aspartato Aminotransferasas/sangre , Bilirrubina/sangre , Colestasis/inducido químicamente , Colestasis/metabolismo , Colestasis/patología , Sinergismo Farmacológico , Emodina/sangre , Frutas , Iridoides/sangre , Hígado/efectos de los fármacos , Hígado/patología , Masculino , Extractos Vegetales/sangre , Extractos Vegetales/farmacocinética , Extractos Vegetales/farmacología , Sustancias Protectoras/farmacocinética , Sustancias Protectoras/farmacología , Ratas Sprague-Dawley , Rizoma
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...